M&A Deal Summary |
|
|---|---|
| Date | 2024-08-27 |
| Target | Medtronic - Paceart Optima System |
| Sector | Medical Products |
| Buyer(s) | PaceMate |
| Sellers(s) | Medtronic |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
PaceMate provides a software and service solution for remote cardiac device management to hospital systems and independent cardiology clinics. PaceMate was founded in 2015 and is based in Bradenton, Florida.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Medical Products) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| Country (Ireland) | 1 of 1 |
| Year (2024) | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1949 |
| Sector | Medical Products |
| Employees | 95,000 |
| Revenue | 32.4B USD (2024) |
Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. It serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Dublin, Ireland with its operational headquarters in Fridley, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector (Medical Products) | 4 of 4 |
| Type (Divestiture) | 5 of 5 |
| Country (Ireland) | 1 of 1 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-05-25 |
EOFlow
Seongnam, South Korea EOFlow is a medical device company. EOFlow's flagship product is the EOPatch® device, a wearable insulin patch pump that provides continuous insulin delivery for people with diabetes. EOFlow was founded in 2011 and is based in Seongnam, South Korea. |
Buy | - |
